Lysophospholipid receptor activation of RhoA and lipid signaling pathways

Por Xiang, Sunny Yang, Dusaban, Stephanie S., Brown, Joan Heller
Publicado em 2012

Revisited and Revised: Is RhoA Always a Villain in Cardiac Pathophysiology?

Por Miyamoto, Shigeki, Del Re, Dominic P., Xiang, Sunny Y., Zhao, Xia, Florholmen, Geir, Brown, Joan Heller
Publicado em 2010

PLCε, PKD1, and SSH1L Transduce RhoA Signaling to Protect Mitochondria from Oxidative Stress in the Heart

Por Xiang, Sunny Y., Ouyang, Kunfu, Yung, Bryan S., Miyamoto, Shigeki, Smrcka, Alan V., Chen, Ju, Brown, Joan Heller
Publicado em 2013

Activation of Volume Regulated Chloride Channels Protects Myocardium from Ischemia/reperfusion Damage in Second-window Ischemic Preconditioning

Por Bozeat, Nathan D., Xiang, Sunny Yang, Ye, Linda L., Yao, Tammy Y., Duan, Marie L., Burkin, Dean J., Lamb, Fred S., Duan, Dayue Darrel
Publicado em 2011

CaMKIIδ subtypes differentially regulate infarct formation following ex vivo myocardial ischemia/reperfusion through NF-κB and TNF-α

Por Gray, Charles B.B., Suetomi, Takeshi, Xiang, Sunny, Mishra, Shikha, Blackwood, Erik A., Glembotski, Christopher C., Miyamoto, Shigeki, Westenbrink, B. Daan, Brown, Joan Heller
Publicado no J Mol Cell Cardiol (2017)

Characterization of a critical role for CFTR chloride channels in cardioprotection against ischemia/reperfusion injury

Por Xiang, Sunny Yang, Ye, Linda L, Duan, Li-lu Marie, Liu, Li-hui, Ge, Zhi-dong, Auchampach, John A, Gross, Garrett J, Duan, Dayue Darrel
Publicado em 2011

Selective Coupling of the S1P(3) Receptor Subtype to S1P-mediated RhoA Activation and Cardioprotection

Por Yung, Bryan S., Brand, Cameron S., Xiang, Sunny Y., Gray, Charles B. B., Means, Christopher K., Rosen, Hugh, Chun, Jerold, Purcell, Nicole, Brown, Joan Heller, Miyamoto, Shigeki
Publicado no J Mol Cell Cardiol (2016)

Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection

Por Zhao, Xia, Ding, Eric Y., Yu, Olivia, Xiang, Sunny Y., Tan-Sah, Valerie P., Yung, Bryan S., Hedgpeth, Joe, Neubig, Richard R., Lau, Lester F., Brown, Joan Heller, Miyamoto, Shigeki
Publicado em 2014

RhoA protects the mouse heart against ischemia/reperfusion injury

Por Xiang, Sunny Yang, Vanhoutte, Davy, Del Re, Dominic P., Purcell, Nicole H., Ling, Haiyun, Banerjee, Indroneal, Bossuyt, Julie, Lang, Richard A., Zheng, Yi, Matkovich, Scot J., Miyamoto, Shigeki, Molkentin, Jeffery D., Dorn, Gerald W., Brown, Joan Heller
Publicado em 2011

EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma

Por Randolph, Matthew E., Cleary, Megan M., Bajwa, Zia, Svalina, Matthew N., Young, Michael C., Mansoor, Atiya, Kaur, Pali, Bult, Carol J., Goros, Martin W., Michalek, Joel E., Xiang, Sunny, Keck, James, Krasnoperov, Valery, Gill, Parkash, Keller, Charles
Publicado no PLoS One (2017)

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma

Por Bharathy, Narendra, Svalina, Matthew N., Settelmeyer, Teagan P., Cleary, Megan M., Berlow, Noah E., Airhart, Susan D., Xiang, Sunny, Keck, James, Hayden, James B., Shern, Jack F., Mansoor, Atiya, Lathara, Melvin, Srinivasa, Ganapati, Langenau, David M., Keller, Charles
Publicado no Oncotarget (2017)